Prescribing Information

Filter

C-APROM/GB/RDG/0114

July 2024

Adverse event reporting information can be found at the bottom of this page

Materials for use with patients

Download
ADVATE (octocog alfa) reconstitution guide for patients
Download
ADVATE (octocog alfa) booklet for patients
Download
Living with haemophilia: A teacher’s guide

Disease Awareness

Article

CEPROTIN (human protein C): Dosing and administration 

Article

CEPROTIN (human protein c): Clinical Data & Safety information 

Article

What is Severe Congenital Protein C Deficiency

Download
Living with haemophilia: A teacher’s guide
Download
VEYVONDI® (vonicog alfa) Dosing Tool
All content
Article
5bdmbanner
5th Bleeding Disorders Masterclass Hot Topics
Video
Haemophilia A and Cardiovascular Disease Case Study
Video
Diagnosis and Management of Von Willebrand Disease
Video
Von Willebrand Disease C-Section Case Study
Download
Living with Haemophilia: A guide to mild & moderate haemophilia
Download
ADVATE (octocog alfa) reconstitution guide for patients
Article

CEPROTIN (human protein C): Dosing and administration 

Article

CEPROTIN (human protein c): Clinical Data & Safety information 

Download
ADVATE (octocog alfa) booklet for patients
Article

What is Severe Congenital Protein C Deficiency

Download
Living with haemophilia: A teacher’s guide
Video
VEYVONDI® (vonicog alfa) On-Demand Real-World Experience With Dr. Carolyn Millar
Video
VEYVONDI® (vonicog alfa) In-Surgery Real-World Experience With Dr. Carolyn Millar
Download
VEYVONDI® (vonicog alfa) Dosing Tool

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard

Adverse events should also be reported to Takeda UK Ltd. at: AE.GBR-IRL@takeda.com

 

Rare Disease Hub is for UK healthcare professionals only. This website has been initiated and developed by Takeda.

Copyright © 2024 Takeda UK Ltd.